Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
317.10B
Market cap317.10B
Price-Earnings ratio
35.31
Price-Earnings ratio35.31
Dividend yield
2.65%
Dividend yield2.65%
Average volume
13.57M
Average volume13.57M
High today
$128.82
High today$128.82
Low today
$125.49
Low today$125.49
Open price
$125.83
Open price$125.83
Volume
18.89M
Volume18.89M
52 Week high
$128.82
52 Week high$128.82
52 Week low
$76.66
52 Week low$76.66

Stock Snapshot

With a market cap of 317.1B, Merck(MRK) trades at $127.53. The stock has a price-to-earnings ratio of 35.31 and currently yields dividends of 2.65%.

As of 2026-06-26, Merck(MRK) stock has fluctuated between $125.49 and $128.82. The current price stands at $127.53, placing the stock +1.6% above today's low and -1.0% off the high.

The Merck(MRK)'s current trading volume is 18.89M, compared to an average daily volume of 13.57M.

In the last year, Merck(MRK) shares hit a 52-week high of $128.82 and a 52-week low of $76.66.

In the last year, Merck(MRK) shares hit a 52-week high of $128.82 and a 52-week low of $76.66.

MRK News

Quartz 10h
Merck KGaA to acquire Bio-Techne in $11.3 billion deal - qz.com

...

Merck KGaA to acquire Bio-Techne in $11.3 billion deal - qz.com
Benzinga 13h
Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC’s ‘Final Trades’

Qualcomm outlined the acceleration of its diversification strategy at its 2026 Investor Day on June 24. In connection with the event, the semiconductor company...

Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC’s ‘Final Trades’
Simply Wall St 1d
Merck Agrees $11.3 Billion Bio Techne Deal To Grow Life Sciences Reach

Merck KGaA, traded in the U.S. via NYSE:MRK, agreed to acquire Bio-Techne Corporation in an US$11.3b transaction. The deal is structured to expand Merck KGaA’s...

Merck Agrees $11.3 Billion Bio Techne Deal To Grow Life Sciences Reach

Analyst ratings

71%

of 31 ratings
Buy
71%
Hold
25.8%
Sell
3.2%

More MRK News

TipRanks 2d
Merck says FDA approves Keytruda and Keytruda Qlex in combo with Trodelvy

Merck (MRK) announced the U.S. FDA approved Keytruda and Keytruda Qlex, each in combination with Trodelvy, Gilead’s (GILD) Trop-2-directed antibody-drug conjuga...

The Wall Street Journal 2d
Germany’s Merck to Buy Bio-Techne for $11 Billion

Merck said the deal for Bio-Techne will be funded through a combination of existing cash and new debt. Ralph Orlowski / REUTERS Germany’s Merck MRK 0.25 %incre...

Germany’s Merck to Buy Bio-Techne for $11 Billion
Simply Wall St 4d
Merck Stock Could Be 11% Undervalued After June Pipeline Wins

Merck (MRK) stock is drawing fresh attention after a cluster of June 2026 pipeline milestones, including new FDA approvals for KEYTRUDA plus WELIREG and CAPVAXI...

Merck Stock Could Be 11% Undervalued After June Pipeline Wins
Benzinga 4d
Merck Scores Key Phase 3 Win For Novel Ulcerative Colitis Therapy

Positive Data For Tulisokibart In Ulcerative Colitis The company announced that the Phase 3 ATLAS-UC induction-only study, also known as Study 2, met its prima...

Merck Scores Key Phase 3 Win For Novel Ulcerative Colitis Therapy

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.